Rhythm Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-05 11:22:56 ET RYTM

Published on 05/05/2026 at 11:22 am EDT

Rhythm Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 60.11 million compared to USD 32.7 million a year ago. Net loss was USD 55.64 million compared to USD 49.5 million a year ago.

Basic loss per share from continuing operations was USD 0.83 compared to USD 0.81 a year ago. Diluted loss per share from continuing operations was USD 0.83 compared to USD 0.81 a year ago.